Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Meng Ding, Jun Pan, Zhicheng Guo, Quhe Liu, Chunhua Yang & Lijun Mao. (2018) SATB1 is a Novel Molecular Target for Cancer Therapy. Cancer Investigation 36:1, pages 28-36.
Read now
Read now
Alexis Lacout, Juliette Thariat & Pierre Yves Marcy. (2012) Letter: “Prognostic Value of Initial Tumor Parameters After Metastatic Relapse: Do Not Miss the Tumoral Stroma”. Cancer Investigation 30:6, pages 493-493.
Read now
Read now
Articles from other publishers (12)
Yuxin Xie, Ji Ma, Xueming Xia, Hong Zheng & Qiheng Gou. (2022) Prognosis and Treatment of Metastatic Breast Cancer From A Real-World Scenario in China: A Retrospective Cohort Study. Cancer Control 29, pages 107327482211305.
Crossref
Crossref
Carlos H. Barcenas, Juhee Song, Rashmi K. Murthy, Akshara S. Raghavendra, Yisheng Li, Limin Hsu, Robert W. Carlson, Debu Tripathy & Gabriel N. Hortobagyi. (2021) Prognostic Model for De Novo and Recurrent Metastatic Breast Cancer. JCO Clinical Cancer Informatics:5, pages 789-804.
Crossref
Crossref
Shuai Li, Jiayi Wu, Ou Huang, Jianrong He, Li Zhu, Weiguo Chen, Yafen Li, Xiaosong Chen & Kunwei Shen. (2020) HER2 positivity is not associated with adverse prognosis in high-risk estrogen receptor-positive early breast cancer patients treated with chemotherapy and trastuzumab. The Breast 54, pages 235-241.
Crossref
Crossref
Victoria Sopik, Ping Sun & Steven A. Narod. (2018) Predictors of time to death after distant recurrence in breast cancer patients. Breast Cancer Research and Treatment 173:2, pages 465-474.
Crossref
Crossref
Federico Pessina, Pierina Navarria, Marco Riva, Davide Franceschini, Marco Conti Nibali, Maurizio Fornari & Marta Scorsetti. (2018) Long-Term Follow-Up of Patients with Metastatic Epidural Spinal Cord Compression from Breast Cancer Treated with Surgery Followed by Radiotherapy. World Neurosurgery 110, pages e281-e286.
Crossref
Crossref
Daniel M. Sciubba, C. Rory Goodwin, Alp Yurter, Derek Ju, Ziya L. Gokaslan, Charles Fisher, Laurence D. Rhines, Michael G. Fehlings, Daryl R. Fourney, Ehud Mendel, Ilya Laufer, Chetan Bettegowda, Shreyaskumar R. Patel, Y. Raja Rampersaud, Arjun Sahgal, Jeremy Reynolds, Dean Chou, Michael H. Weber & Michelle J. Clarke. (2015) A Systematic Review of Clinical Outcomes and Prognostic Factors for Patients Undergoing Surgery for Spinal Metastases Secondary to Breast Cancer. Global Spine Journal 6:5, pages 482-496.
Crossref
Crossref
Zhiyong Ren, Yufeng Li, Tiansheng Shen, Omar Hameed, Gene P. Siegal & Shi Wei. (2016) Prognostic factors in advanced breast cancer: Race and receptor status are significant after development of metastasis. Pathology - Research and Practice 212:1, pages 24-30.
Crossref
Crossref
C. Dilara Savci-Heijink, Hans Halfwerk, Gerrit K. J. Hooijer, Hugo M. Horlings, Jelle Wesseling & Marc J. van de Vijver. (2015) Retrospective analysis of metastatic behaviour of breast cancer subtypes. Breast Cancer Research and Treatment 150:3, pages 547-557.
Crossref
Crossref
Hee Jun KimSung Gwe AhnHak Min LeeJong Tae ParkKyunghwa HanSeung Ah LeeJoon Jeong. (2015) Metastasis-Free Interval Is Closely Related to Tumor Characteristics and Has Prognostic Value in Breast Cancer Patients with Distant Relapse. Journal of Breast Cancer 18:4, pages 371.
Crossref
Crossref
A. B. G. Kwast, A. C. Voogd, M. B. E. Menke-Pluijmers, S. C. Linn, G. S. Sonke, L. A. Kiemeney & S. Siesling. (2014) Prognostic factors for survival in metastatic breast cancer by hormone receptor status. Breast Cancer Research and Treatment 145:2, pages 503-511.
Crossref
Crossref
Zhiyong Ren, Yufeng Li, Omar Hameed, Gene P. Siegal & Shi Wei. (2014) Prognostic factors in patients with metastatic breast cancer at the time of diagnosis. Pathology - Research and Practice 210:5, pages 301-306.
Crossref
Crossref
Dorien J. A. Lobbezoo, Roel J. W. van Kampen, Adri C. Voogd, M. Wouter Dercksen, Franchette van den Berkmortel, Tineke J. Smilde, Agnes J. van de Wouw, Frank P. J. Peters, Johanna M. G. H. van Riel, Natascha A. J. B. Peters, Maaike de Boer, George F. Borm & Vivianne C. G. Tjan-Heijnen. (2013) Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome. Breast Cancer Research and Treatment 141:3, pages 507-514.
Crossref
Crossref